Shenouda Maged — SEC Form 4 filings
SEC reporting owner CIK 1658369. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-31 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 13 legs across 6 filings — 997,772 shares, $2,364,675 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: purchase of 500,000 shares @ $2.20 ($1,100,000) in RELMADA THERAPEUTICS, INC., filed 2025-11-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | Chief Financial Officer | 8 | 13 legs · 997,772 sh · $2,364,675 | — | 4 |
Form 4 filings — Shenouda Maged
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 120,200 @ $4.20 · Purchase (P): 79,800 @ $4.25 | EDGAR |
| 2025-12-16 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 11,665 @ $4.12 · Grant/award (A): 828,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 500,000 @ $2.20 | EDGAR |
| 2025-06-30 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 50,000 @ $0.44 · Purchase (P): 90,000 @ $0.49 · Purchase (P): 60,000 @ $0.52 | EDGAR |
| 2024-09-11 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 8,194 @ $2.55 · Purchase (P): 21,118 @ $2.73 · Purchase (P): 24,120 @ $2.95 | EDGAR |
| 2024-05-29 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Grant/award (A): 54,624 (derivative) @ $0 · Other (J): 54,624 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | RELMADA THERAPEUTICS, INC. (RLMD) | Purchase (P): 10,800 @ $3.65 · Purchase (P): 15,000 @ $3.89 · Purchase (P): 6,875 @ $4.06 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1658369 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →